NR4A1 and breast carcinoma: in 2013, where the CYP2D6*10 minor allele frequency in a Sri Lankan population (n = 75) was reported to be 39%, similar to the 37.9% obtained in the cohort of 70 hormone receptor positive breast cancer patients genotyped in this study.